{"id":"https://openalex.org/W2563096962","doi":"https://doi.org/10.1055/s-0042-120120","title":"PPAR-\u03b3 Agonists for the Treatment of Major Depression: A Review","display_name":"PPAR-\u03b3 Agonists for the Treatment of Major Depression: A Review","alternate_titles":[],"publication_year":2016,"publication_date":"2016-12-15","ids":{"openalex":"https://openalex.org/W2563096962","doi":"https://doi.org/10.1055/s-0042-120120","mag":"2563096962","pmid":"https://pubmed.ncbi.nlm.nih.gov/27978584"},"language":"en","primary_location":{"id":"doi:10.1055/s-0042-120120","doi":"https://doi.org/10.1055/s-0042-120120","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0042-120120","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},"parent_works":[],"lineage":["https://openalex.org/W2563096962"],"child_works_count":0,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5033082036","display_name":"Romain Colle","orcid":"https://orcid.org/0000-0002-2549-4495","observed_orcids":["https://orcid.org/0000-0002-2549-4495"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":true,"contributor_roles":[],"raw_author_name":"R. Colle","raw_affiliation_strings":["University Paris-Sud, Le Kremlin Bic\u00eatre, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Paris-Sud, Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":null,"display_name":"D. de Larminat","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"D. de Larminat","raw_affiliation_strings":["University Paris-Sud, Le Kremlin Bic\u00eatre, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Paris-Sud, Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":null,"display_name":"S. Rotenberg","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"S. Rotenberg","raw_affiliation_strings":["University Paris-Sud, Le Kremlin Bic\u00eatre, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Paris-Sud, Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5004441681","display_name":"Franz Hozer","orcid":"https://orcid.org/0000-0003-4592-0532","observed_orcids":["https://orcid.org/0000-0003-4592-0532"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"F. Hozer","raw_affiliation_strings":["University Paris-Sud, Le Kremlin Bic\u00eatre, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Paris-Sud, Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5111206442","display_name":"P. Hardy","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"P. Hardy","raw_affiliation_strings":["University Paris-Sud, Le Kremlin Bic\u00eatre, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Paris-Sud, Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5086352483","display_name":"C\u00e9line Verstuyft","orcid":"https://orcid.org/0000-0002-8534-224X","observed_orcids":["https://orcid.org/0000-0002-8534-224X"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]},{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"C. Verstuyft","raw_affiliation_strings":["University Paris-Sud, Le Kremlin Bic\u00eatre, France","INSERM UMR_S1184, Centre IMVA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Paris-Sud, Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404"]},{"raw_affiliation_string":"INSERM UMR_S1184, Centre IMVA","institution_ids":["https://openalex.org/I154526488"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018886514","display_name":"Bruno F\u00e8ve","orcid":"https://orcid.org/0000-0001-6577-9009","observed_orcids":["https://orcid.org/0000-0001-6577-9009"]},"institutions":[{"id":"https://openalex.org/I154526488","display_name":"Inserm","ror":"https://ror.org/02vjkv261","country_code":"FR","type":"government","lineage":["https://openalex.org/I154526488"]},{"id":"https://openalex.org/I4210134622","display_name":"Centre de Recherche Saint-Antoine","ror":"https://ror.org/03wxndv36","country_code":"FR","type":"facility","lineage":["https://openalex.org/I154526488","https://openalex.org/I39804081","https://openalex.org/I4210097159","https://openalex.org/I4210129850","https://openalex.org/I4210134622"]},{"id":"https://openalex.org/I4405264447","display_name":"Universit\u00e9 Pierre-et-Marie-Curie","ror":"https://ror.org/01yvrd251","country_code":"FR","type":"education","lineage":["https://openalex.org/I39804081","https://openalex.org/I4405264447"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"B. F\u00e8ve","raw_affiliation_strings":["Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie, Centre de Recherche Saint-Antoine, INSERM UMR_S938, Paris, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sorbonne Universit\u00e9s, Universit\u00e9 Pierre et Marie Curie, Centre de Recherche Saint-Antoine, INSERM UMR_S938, Paris, France","institution_ids":["https://openalex.org/I154526488","https://openalex.org/I4210134622","https://openalex.org/I4405264447"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078636406","display_name":"Emmanuelle Corruble","orcid":"https://orcid.org/0000-0002-9441-6079","observed_orcids":["https://orcid.org/0000-0002-9441-6079"]},"institutions":[{"id":"https://openalex.org/I102197404","display_name":"Universit\u00e9 Paris-Sud","ror":"https://ror.org/028rypz17","country_code":"FR","type":"education","lineage":["https://openalex.org/I102197404","https://openalex.org/I277688954"]}],"countries":["FR"],"is_corresponding":false,"contributor_roles":[],"raw_author_name":"E. Corruble","raw_affiliation_strings":["University Paris-Sud, Le Kremlin Bic\u00eatre, France"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Paris-Sud, Le Kremlin Bic\u00eatre, France","institution_ids":["https://openalex.org/I102197404"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":["https://openalex.org/A5033082036"],"corresponding_institution_ids":["https://openalex.org/I102197404"],"apc_list":null,"apc_paid":null,"fwci":5.1809,"has_fulltext":false,"cited_by_count":103,"reviewed_by_count":0,"citation_normalized_percentile":{"value":0.96206595,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":99},"biblio":{"volume":"50","issue":"02","first_page":"49","last_page":"55"},"is_retracted":false,"is_pulled":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11071","display_name":"Treatment of Major Depression","score":0.9980000257492065,"subfield":{"id":"https://openalex.org/subfields/2736","display_name":"Pharmacology (medical)"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11337","display_name":"Tryptophan and brain disorders","score":0.0010999999940395355,"subfield":{"id":"https://openalex.org/subfields/2803","display_name":"Biological Psychiatry"},"field":{"id":"https://openalex.org/fields/28","display_name":"Neuroscience"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11072","display_name":"Peroxisome Proliferator-Activated Receptors","score":0.0003000000142492354,"subfield":{"id":"https://openalex.org/subfields/1312","display_name":"Molecular Biology"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/ppargamma-agonists","display_name":"PPAR\u03b3 agonists","score":0.9850000143051147},{"id":"https://openalex.org/keywords/major-depressive-disorder","display_name":"major depressive disorder","score":0.9639999866485596},{"id":"https://openalex.org/keywords/antidepressant-effects","display_name":"antidepressant effects","score":0.8349999785423279},{"id":"https://openalex.org/keywords/pioglitazone","display_name":"pioglitazone","score":0.9980000257492065},{"id":"https://openalex.org/keywords/rosiglitazone","display_name":"rosiglitazone","score":1.0},{"id":"https://openalex.org/keywords/insulin-resistance","display_name":"insulin resistance","score":0.949999988079071},{"id":"https://openalex.org/keywords/inflammation","display_name":"inflammation","score":0.7870000004768372},{"id":"https://openalex.org/keywords/interleukin-6","display_name":"interleukin-6","score":0.9729999899864197},{"id":"https://openalex.org/keywords/homa-ir","display_name":"HOMA-IR","score":0.9430000185966492},{"id":"https://openalex.org/keywords/glucose-tolerance","display_name":"glucose tolerance","score":0.6660000085830688},{"id":"https://openalex.org/keywords/metformin","display_name":"metformin","score":0.7260000109672546},{"id":"https://openalex.org/keywords/adjunctive-therapy","display_name":"adjunctive therapy","score":0.5450000166893005}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6722801923751831},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.5905343294143677},{"id":"https://openalex.org/C2777391703","wikidata":"https://www.wikidata.org/wiki/Q1053470","display_name":"Insulin resistance","level":3,"score":0.5840633511543274},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.570517361164093},{"id":"https://openalex.org/C2780152017","wikidata":"https://www.wikidata.org/wiki/Q424771","display_name":"Rosiglitazone","level":3,"score":0.5439209938049316},{"id":"https://openalex.org/C2777180221","wikidata":"https://www.wikidata.org/wiki/Q3025883","display_name":"Type 2 diabetes","level":3,"score":0.523813784122467},{"id":"https://openalex.org/C3018667095","wikidata":"https://www.wikidata.org/wiki/Q3455903","display_name":"Glucose homeostasis","level":4,"score":0.5148562788963318},{"id":"https://openalex.org/C2780323712","wikidata":"https://www.wikidata.org/wiki/Q19484","display_name":"Metformin","level":3,"score":0.5131354928016663},{"id":"https://openalex.org/C197934379","wikidata":"https://www.wikidata.org/wiki/Q2047938","display_name":"Adverse effect","level":2,"score":0.4574510455131531},{"id":"https://openalex.org/C98274493","wikidata":"https://www.wikidata.org/wiki/Q128406","display_name":"Pharmacology","level":1,"score":0.45451661944389343},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.45220187306404114},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.44099393486976624},{"id":"https://openalex.org/C134018914","wikidata":"https://www.wikidata.org/wiki/Q162606","display_name":"Endocrinology","level":1,"score":0.43328139185905457},{"id":"https://openalex.org/C2778384471","wikidata":"https://www.wikidata.org/wiki/Q417765","display_name":"Pioglitazone","level":4,"score":0.42891842126846313},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.3547484874725342},{"id":"https://openalex.org/C555293320","wikidata":"https://www.wikidata.org/wiki/Q12206","display_name":"Diabetes mellitus","level":2,"score":0.34342795610427856},{"id":"https://openalex.org/C2779306644","wikidata":"https://www.wikidata.org/wiki/Q2002370","display_name":"Insulin","level":2,"score":0.26739436388015747},{"id":"https://openalex.org/C2781161787","wikidata":"https://www.wikidata.org/wiki/Q48360","display_name":"Hippocampus","level":2,"score":0.0},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000077154","descriptor_name":"Rosiglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000077205","descriptor_name":"Pioglitazone","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000928","descriptor_name":"Antidepressive Agents","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001786","descriptor_name":"Blood Glucose","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D003865","descriptor_name":"Major Depressive Disorder","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D005215","descriptor_name":"Fasting","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005951","descriptor_name":"Glucose Tolerance Test","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007333","descriptor_name":"Insulin Resistance","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D015415","descriptor_name":"Biomarkers","qualifier_ui":"Q000378","qualifier_name":"metabolism","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D045162","descriptor_name":"Thiazolidinediones","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D047495","descriptor_name":"PPAR gamma","qualifier_ui":"Q000819","qualifier_name":"agonists","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1055/s-0042-120120","doi":"https://doi.org/10.1055/s-0042-120120","is_oa":false,"landing_page_url":"https://doi.org/10.1055/s-0042-120120","pdf_url":null,"source":{"id":"https://openalex.org/S4122505","display_name":"Pharmacopsychiatry","issn_l":"0176-3679","issn":["0176-3679","1439-0795"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","medline","norway-1","poland-70","russia-white-list-1"],"host_organization":"https://openalex.org/P4310320000","host_organization_name":"Thieme Medical Publishers (Germany)","host_organization_lineage":["https://openalex.org/P4310320000"],"host_organization_lineage_names":["Thieme Medical Publishers (Germany)"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"journal-article"},{"id":"pmid:27978584","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/27978584","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Pharmacopsychiatry","raw_type":"Journal Article"},{"id":"pmh:oai:HAL:hal-04021197v1","doi":null,"is_oa":false,"landing_page_url":"https://hal.science/hal-04021197","pdf_url":null,"source":{"id":"https://openalex.org/S4306402512","display_name":"HAL","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I4405252976","host_organization_name":"Centre pour la Communication Scientifique Directe","host_organization_lineage":["https://openalex.org/I4405252976"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"Pharmacopsychiatry, 2017, 50 (02), pp.49-55. &#x27E8;10.1055/s-0042-120120&#x27E9;","raw_type":"info:eu-repo/semantics/article"}],"best_oa_location":null,"sustainable_development_goals":[{"score":1.0,"id":"https://metadata.un.org/sdg/3","display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2564398793","https://openalex.org/W7171974171","https://openalex.org/W2527763513","https://openalex.org/W7212079764","https://openalex.org/W2979638759","https://openalex.org/W4416844600","https://openalex.org/W2947102412","https://openalex.org/W2079344641","https://openalex.org/W4386052603","https://openalex.org/W3161276014"],"abstract_inverted_index":{"Introduction:":[0],"Selective":[1],"agonists":[2,82,100,160],"of":[3,17,30,36,45,76,113,133,151,173],"the":[4,15,28,34,105],"nuclear":[5],"transcription":[6],"factor":[7],"peroxisome":[8],"proliferator-activated":[9],"receptor-gamma":[10],"(PPAR-\u03b3)":[11],"are":[12],"used":[13],"for":[14,27,86],"treatment":[16,29],"type":[18],"2":[19],"diabetes.":[20],"We":[21],"reviewed":[22],"their":[23,37],"efficacy":[24],"and":[25,33,47,56,65,109,144,148],"safety":[26],"major":[31,72,117,174],"depression":[32,73,124],"association":[35],"potential":[38],"antidepressant":[39,102,163],"effects":[40,103],"with":[41,71,128],"changes":[42],"in":[43,92,104,110,123,130,170],"biomarkers":[44,132,156],"metabolism":[46],"inflammation.":[48],"Methods:":[49],"From":[50],"8":[51],"studies,":[52],"4":[53,57,106,114],"open-label":[54,107],"trials,":[55],"randomized":[58],"controlled":[59],"trials":[60],"(RCT)":[61],"(3":[62],"vs.":[63,67],"placebo":[64],"1":[66,149],"metformin),":[68],"448":[69],"patients":[70,79],"were":[74],"included,":[75],"which":[77,165],"209":[78],"received":[80],"PPAR-\u03b3":[81,99,159],"(pioglitazone":[83],"or":[84,91],"rosiglitazone)":[85],"6\u201312":[87],"weeks,":[88],"either":[89],"alone":[90],"add-on":[93],"therapy":[94],"to":[95,167],"conventional":[96],"treatments.":[97],"Results:":[98],"have":[101,162],"studies":[108,172],"3":[111,131],"out":[112],"RCT.":[115],"No":[116],"adverse":[118],"event":[119],"was":[120,126],"reported.":[121],"Improvement":[122],"scores":[125],"associated":[127],"improvement":[129],"insulin":[134],"resistance":[135],"(homeostatic":[136],"model":[137],"assessment":[138],"[HOMA-IR],":[139],"oral":[140],"glucose":[141],"tolerance":[142],"test,":[143],"fasting":[145],"plasma":[146],"glucose)":[147],"biomarker":[150],"inflammation":[152],"(interleukin-6)":[153],"among":[154],"21":[155],"studied.":[157],"Conclusion:":[158],"may":[161],"properties,":[164],"need":[166],"be":[168],"assessed":[169],"further":[171],"depressive":[175],"episodes.":[176]},"cited_by_api_url":"https://api.openalex.org/works?filter=cites:W2563096962","counts_by_year":[{"year":2026,"cited_by_count":7},{"year":2025,"cited_by_count":12},{"year":2024,"cited_by_count":8},{"year":2023,"cited_by_count":6},{"year":2022,"cited_by_count":11},{"year":2021,"cited_by_count":13},{"year":2020,"cited_by_count":15},{"year":2019,"cited_by_count":11},{"year":2018,"cited_by_count":10},{"year":2017,"cited_by_count":10}],"updated_date":"2026-11-21T10:27:49.728292","created_date":"2017-01-06T00:00:00"}
